ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,540Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 307

$558K Total Retail Price of All Prescriptions

Rank: 14 out of 307

434 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 434 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

11% of this provider’s 434 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 7,102 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LEVOTHYROXINE SODIUM 531 389 1 1
SIMVASTATIN 510 374 2 2
LISINOPRIL 420 325 3 3
OMEPRAZOLE 347 183 4 5
AMLODIPINE BESYLATE 288 228 5 7
TAMSULOSIN HCL 284 190 6 21
HYDROCHLOROTHIAZIDE 234 211 7 9
FUROSEMIDE 213 146 8 6
METFORMIN HCL 190 163 9 8
METOPROLOL SUCCINATE 186 169 10 13
ZOLPIDEM TARTRATE 161 143 11 19
ATENOLOL 161 126 11 17
HYDROCODONE-ACETAMINOPHEN 150 104 S3 13 4
LOSARTAN POTASSIUM 149 139 14 16
WARFARIN SODIUM 133 107 15 11
ENALAPRIL MALEATE 132 116 16 54
ADVAIR DISKUS 131 98 17 28
POTASSIUM CHLORIDE 128 86 18 10
ALLOPURINOL 118 104 19 27
METOPROLOL TARTRATE 116 104 20 12
PRAVASTATIN SODIUM 108 98 21 26
POLYETHYLENE GLYCOL 3350 97 14 22 50
CITALOPRAM HBR 95 14 23 14
ATORVASTATIN CALCIUM 94 74 24 18
CRESTOR 88 70 25 39
GABAPENTIN 84 48 26 15
OXYCODONE HCL 78 31 S2 27 31
ALENDRONATE SODIUM 78 31 27 20
COMBIVENT 77 62 29 90
MELOXICAM 76 57 30 29
METFORMIN HCL ER 75 65 31 52
FLUTICASONE PROPIONATE 73 42 32 44
FINASTERIDE 69 57 33 105
DIGOXIN 69 46 33 36
FLUOXETINE HCL 69 67 33 32
MIRTAZAPINE 64 43 36 51
DONEPEZIL HCL 63 50 37 34
NEXIUM 63 29 37 38
DIOVAN 62 38 39 58
SERTRALINE HCL 61 48 40 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 34 40 23
LAMOTRIGINE 60 0 42 164
GLIMEPIRIDE 59 59 43 60
TRAZODONE HCL 58 25 44 33
CLOPIDOGREL 57 53 45 59
CYCLOBENZAPRINE HCL 55 26 R 46 75
LOVASTATIN 53 21 47 45
ISOSORBIDE MONONITRATE ER 53 53 47 78
METOCLOPRAMIDE HCL 53 30 47 108
CYMBALTA 51 40 50 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 24, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.